Prednisolone and cefapirin act synergistically in resolving experimental Escherichia coli mastitis

Journal of Dairy Science

Volumn 96, Issue 7, 2013, Pages 4406-4418

  Sipka, Anja ^a   Gurjar, Abhijit ^a   Klaessig, Suzanne ^a   Duhamel, Gerald E ^a   Skidmore, Andrew ^b   Swinkels, Jantijn ^b   Cox, Peter ^b   Schukken, Ynte ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MERCK ANIMAL HEALTH   (United States)

Author keywords

Corticosteroid; Escherichia coli mastitis; Inflammatory response

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CEFAPIRIN; CYTOKINE; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CATTLE; CELL COUNT; CYTOLOGY; DRUG COMBINATION; DRUG POTENTIATION; ESCHERICHIA COLI INFECTION; FEMALE; LACTATION; MICROBIOLOGY; MILK; PATHOLOGY; PATHOPHYSIOLOGY; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CATTLE; CELL COUNT; CEPHAPIRIN; CYTOKINES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI INFECTIONS; FEMALE; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; PREDNISOLONE;

BACTERIA (MICROORGANISMS); BOS; ESCHERICHIA COLI; FRIESIA;

EID: 84879283535     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-6455     Document Type: Article

References (34)

1. Bannerman D.D. Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J. Anim. Sci. 2009, 87(Suppl.):10-25.
2. Bannerman D.D., Paape M.J., Lee J.W., Zhao X., Hope J.C., Rainard P. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin. Diagn. Lab. Immunol. 2004, 11:463-472.
3. Bianchi M., Meng C., Ivashkiv L.B. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc. Natl. Acad. Sci. USA 2000, 97:9573-9578.
4. Brooks B.M., Hart C.A., Coleman J.W. Differential effects of beta-lactams on human IFN-gamma activity. J. Antimicrob. Chemother. 2005, 56:1122-1125.
5. Brugnolo F., Annunziato F., Sampognaro S., Campi P., Manfredi M., Matucci A., Blanca M., Romagnani S., Maggi E., Parronchi P. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J. Immunol. 1999, 163:1053-1059.
6. Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile A., Duchateau L. Severity of E. coli mastitis is mainly determined by cow factors. Vet. Res. 2003, 34:521-564.
7. Constable P.D., Morin D.E. Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. J. Am. Vet. Med. Assoc. 2002, 221:103-108.
8. Constable P.D., Pyorala S., Smith G.W. Guidelines for antimicrobial use in cattle. Guide to Antimicrobial Use in Animals 2009, 143-160. Blackwell Publishing Ltd., Oxford, UK. L. Guardabassi, L.B. Jensen, H. Kruse (Eds.).
9. Dogan B., Klaessig S., Rishniw M., Almeida R.A., Oliver S.P., Simpson K., Schukken Y.H. Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Vet. Microbiol. 2006, 116:270-282.
10. Dogan B., Rishniw M., Bruant G., Harel J., Schukken Y.H., Simpson K.W. Phylogroup and lpfA influence epithelial invasion by mastitis associated Escherichia coli. Vet. Microbiol. 2012, 159(1-2):163-170.
11. Erskine R.J., Bartlett P.C., VanLente J.L., Phipps C.R. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J. Dairy Sci. 2002, 85:2571-2575.
12. Estes D.M., Hirano A., Heussler V.T., Dobbelaere D.A., Brown W.C. Expression and biological activities of bovine interleukin 4: Effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro. Cell. Immunol. 1995, 163:268-279.
13. Fitzpatrick, C. 2011. Assessing and mediating pain in dairy cows with experimentally-induced clinical mastitis. Page 132 in Population Medicine. Vol. Master of Science. University of Guelph, Guelph, Canada.
14. Goff J.P., Naito Y., Kehrli M.E., Hayes P., Daley M. Physiologic effects of administration of interleukin 1 beta in cows. Am. J. Vet. Res. 1992, 53:1983-1987.
15. Guérin-Faublée V., Carret G., Houffschmitt P. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet. Rec. 2003, 152:466-471.
16. Hsu A.K., Quach H., Tai T., Prince H.M., Harrison S.J., Trapani J.A., Smyth M.J., Neeson P., Ritchie D.S. The immunostimulatory effect of lenalidomide on NK- cell function is profoundly inhibited by concurrent dexamethasone therapy. Blood 2011, 117:1605-1613.
17. Liu M.C., Proud D., Lichtenstein L.M., Hubbard W.C., Bochner B.S., Stealey B.A., Breslin L., Xiao H., Freidhoff L.R., Schroeder J.T., Schleimer R.P. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J. Allergy Clin. Immunol. 2001, 108:29-38.
18. Liu Z., Yuan X., Luo Y., He Y., Jiang Y., Chen Z.K., Sun E. Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. Cytokine 2009, 45:141-147.
19. Lohuis J.A., Van Leeuwen W., Verheijden J.H., Van Miert A.S., Brand A. Effect of dexamethasone on experimental Escherichia coli mastitis in the cow. J. Dairy Sci. 1988, 71:2782-2789.
20. Maeda Y., Tanaka R., Ohtsuka H., Matsuda K., Tanabe T., Oikawa M. Comparison of the immunosuppressive effects of dexamethasone, flunixin meglumine and meloxicam on the in vitro response of calf peripheral blood mononuclear cells. J. Vet. Med. Sci. 2011, 73:957-960.
21. Menge C., Dean-Nystrom E.A. Dexamethasone depletes gammadelta T cells and alters the activation state and responsiveness of bovine peripheral blood lymphocyte subpopulations. J. Dairy Sci. 2008, 91:2284-2298.
22. Miljković Z., Momcilovic M., Miljkovic D., Mostarica-Stojkovic M. Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis. J. Neuroinflammation 2009, 6:37.
23. Moiré N., Roy O., Gardey L. Effects of dexamethasone on distribution and function of peripheral mononuclear blood cells in pneumonic calves. Vet. Immunol. Immunopathol. 2002, 87:459-466.
24. Poutrel B., Stegemann M.R., Roy O., Pothier F., Tilt N., Payne-Johnson M. Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. J. Dairy Res. 2008, 75:310-318.
25. Pyörälä S., Kaartinen L., Kack H., Rainio V. Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows. J. Dairy Sci. 1994, 77:453-461.
26. Rantala M., Kaartinen L., Valimaki E., Stryrman M., Hiekkaranta M., Niemi A., Saari L., Pyorala S. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharmacol. Ther. 2002, 25:251-258.
27. Schukken Y.H., Bennett G.J., Zurakowski M.J., Sharkey H.L., Rauch B.J., Thomas M.J., Ceglowski B., Saltman R.L., Belomestnykh N., Zadoks R.N. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis. J. Dairy Sci. 2011, 94:6203-6215.
28. Schukken Y.H., Gunther J., Fitzpatrick J., Fontaine M.C., Goetze L., Holst O., Leigh J., Petzl W., Schuberth H.J., Sipka A., Smith D.G., Quesnell R., Watts J., Yancey R., Zerbe H., Gurjar A., Zadoks R.N., Seyfert H.M. Host-response patterns of intramammary infections in dairy cows. Vet. Immunol. Immunopathol. 2011, 144:270-289.
29. Schwiebert L.M., Beck L.A., Stellato C., Bickel C.A., Bochner B.S., Schleimer R.P. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 1996, 97:143-152.
30. Spies C.M., Gaber T., Hahne M., Naumann L., Tripmacher R., Schellmann S., Stahn C., Burmester G.R., Radbruch A., Buttgereit F. Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells. Immunol. Lett. 2010, 131:24-32.
31. Suojala L., Simojoki H., Mustonen K., Kaartinen L., Pyorala S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J. Dairy Sci. 2010, 93:1960-1969.
32. Wagner S.A., Apley M.D. Effects of two anti-inflammatory drugs on physiologic variables and milk production in cows with endotoxin-induced mastitis. Am. J. Vet. Res. 2004, 65:64-68.
33. Zen M., Canova M., Campana C., Bettio S., Nalotto L., Rampudda M., Ramonda R., Iaccarino L., Doria A. The kaleidoscope of glucorticoid effects on immune system. Autoimmun. Rev. 2011, 10:305-310.
34. Ziv G., Shem-Tov M., Ascher F. Combined effect of ampicillin, colistin and dexamethasone administered intramuscularly to dairy cows on the clinico-pathological course of E. coli-endotoxin mastitis. Vet. Res. 1998, 29:89-98.